Fortfahren mit
Größe auswählen
| Größe/SKU | Verfügbarkeit | Preis |
|---|---|---|
200 mg | Warenkorb auf Verfügbarkeit prüfen | € 420,00 |
Über diesen Artikel
grade
pharmaceutical primary standard
agency
USP
API family
sulfadiazine
manufacturer/tradename
USP
mp
253 °C (dec.) (lit.)
application(s)
pharmaceutical
pharmaceutical (small molecule)
format
neat
SMILES string
Nc1ccc(cc1)S(=O)(=O)Nc2ncccn2
InChI
1S/C10H10N4O2S/c11-8-2-4-9(5-3-8)17(15,16)14-10-12-6-1-7-13-10/h1-7H,11H2,(H,12,13,14)
InChI key
SEEPANYCNGTZFQ-UHFFFAOYSA-N
General description
Application
- Silver Sulfadiazine Cream
- Sulfadiazine
- Sulfadiazine Sodium
- Sulfadiazine Tablets
Analysis Note
Other Notes
1 of 1
Dieser Artikel | |||
|---|---|---|---|
| description United States Pharmacopeia (USP) Reference Standard | description 99.0-101.0% | description Pharmaceutical Secondary Standard; Certified Reference Material | description European Pharmacopoeia (EP) Reference Standard |
| manufacturer/tradename USP | manufacturer/tradename - | manufacturer/tradename - | manufacturer/tradename EDQM |
| grade pharmaceutical primary standard | grade - | grade certified reference material, pharmaceutical secondary standard | grade pharmaceutical primary standard |
| format neat | format - | format neat | format neat |
| application(s) pharmaceutical (small molecule) | application(s) - | application(s) pharmaceutical (small molecule) | application(s) pharmaceutical (small molecule) |
| agency USP | agency - | agency traceable to Ph. Eur. S1800000, traceable to USP 1625009 | agency - |
| API family sulfadiazine | API family - | API family sulfadiazine | API family sulfadiazine |
Still not finding the right product?
Explore all of our products under Sulfadiazin
Signalwort
Warning
Gefahrencodes
Sicherheitshinweise
Hazard Classifications
Acute Tox. 4 Oral - Aquatic Chronic 2 - Repr. 2
Lagerklasse
11 - Combustible Solids
Hier finden Sie alle aktuellen Versionen:
Besitzen Sie dieses Produkt bereits?
In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.



